About us

SokoLife, Inc. -  ISO 13485:2016-certified developer and contract manufacturer of xenogeneic tissue-engineering materials, based in Eugene, Oregon.

We specialize in bovine pericardium-derived materials for tissue engineering and medical device development, supporting partners from concept through regulatory submission and scale-up manufacturing.

To advance tissue engineering through scalable, quality-controlled processing of bovine pericardium-derived materials, delivered under a certified quality management system.

• Quality systems: Operations run under an ISO 13485:2016-certified quality management system.
• Collaboration: We tailor processing and supply solutions to partner specifications.
• Innovation: Active R&D in decellularized ECM and fixed-pericardium platforms.
• Traceable supply chain: Closed-herd, USDA-sourced bovine tissue with full material traceability (ISO 22442-2:2020).

Application areas under development (for partners and investigators)
Dural repair, surgical reconstruction, and wound care — currently in development and clinical-evidence generation. Additional cardiovascular applications are under investigation outside the United States.

State-of-the-art processing facilities with controlled environments and the quality controls expected of an ISO 13485:2016 operation.

SokoLife products are in development and have not been cleared or approved by the U.S. Food and Drug Administration. They are not available for sale in the United States. Material descriptions reflect development-stage specifications and do not constitute claims of clinical safety or efficacy. International availability varies by jurisdiction.